首页 › 基金 › BML Capital Management, LLC › AVIR
BML Capital Management, LLC 对 AVIR 的持仓历史
ATEA PHARMACEUTICALS INC · 医疗保健
BML Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 AVIR(ATEA PHARMACEUTICALS INC)6,753,658 股,市值约 US$35.2M,约占其申报组合的 18.75%,在其申报持仓中市值排名第 2 位。 BML Capital Management, LLC 最近 13 个申报季度中有 13 个季度披露了 AVIR 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
BML Capital Management, LLC 对 AVIR 的持仓演变
BML Capital Management, LLC 于 Q3 2023 首次披露 AVIR 持仓:4,800,000 股(约 US$14.4M)。 该持仓在 Q1 2026 达到峰值 7,058,657 股,市值约 US$38.0M。 在 13 次申报中,BML Capital Management, LLC 5 次增持、4 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 6,753,658 股、市值约 US$35.2M,环比减持 -198,672 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 4.80M | $14.40M | 新进 |
| Q4 2023 | 5.46M | $16.66M | 增持 |
| Q1 2024 | 5.54M | $22.37M | 增持 |
| Q2 2024 | 6.38M | $21.10M | 增持 |
| Q3 2024 | 6.65M | $22.28M | 增持 |
| Q4 2024 | 7.61M | $25.49M | 增持 |
| Q1 2025 | 7.61M | $22.75M | 持有 |
| Q2 2025 | 7.61M | $27.40M | 持有 |
| Q3 2025 | 7.47M | $21.67M | 减持 |
| Q4 2025 | 7.49M | $26.74M | 持有 |
| Q1 2026 | 7.06M | $37.98M | 减持 |
| Q2 2026 | 6.95M | $32.33M | 减持 |
| Q3 2026 | 6.75M | $35.19M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AVIR 与 13F 数据
AVIR(ATEA PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 AVIR,申报仓位最大的包括:TANG CAPITAL MANAGEMENT LLC (US$22.4M), Bain Capital Life Sciences Investors, LLC (US$9.7M), Rosalind Advisors, Inc. (US$5.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AVIR 的基金
- TANG CAPITAL MANAGEMENT LLC 4.81M 股 · $22.39M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.08M 股 · $9.65M · Q2 2026
- Rosalind Advisors, Inc. 1.07M 股 · $4.98M · Q2 2026
- Royal Palms Capital LLC 71.13K 股 · $2.82M · Q3 2026
- CM Management, LLC 450.00K 股 · $2.34M · Q3 2026
更多关于 BML Capital Management, LLC
常见问题
How long has BML Capital Management, LLC held AVIR?
BML Capital Management, LLC has disclosed AVIR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BML Capital Management, LLC's current position in AVIR?
As of Q3 2026, BML Capital Management, LLC holds 6.75M shares of AVIR (ATEA PHARMACEUTICALS INC), valued at $35.19M, representing 18.75% of its reported portfolio and ranking #2.
Has BML Capital Management, LLC been buying or selling AVIR?
In the latest 13F filing (Q3 2026), BML Capital Management, LLC reduced its position in AVIR. The position peaked in Q1 2026 at 7.06M shares.
Which other funds hold AVIR?
Other major institutional holders of AVIR include TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, Rosalind Advisors, Inc., among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.